{"id":2002,"date":"2017-12-31T00:00:00","date_gmt":"2017-12-30T17:00:00","guid":{"rendered":"https:\/\/www.hivnat.org\/en\/?p=2002"},"modified":"2022-03-30T09:56:31","modified_gmt":"2022-03-30T02:56:31","slug":"a-phase-ii-iii-open-label-study-of-the-pharmacokinetics-safety-and-antiviral-activity-of-the-elvitegravir-cobicistat-emtricitabine-tenofovir-alafenamide-e-c-f-taf-single-tablet-regimen-str-in-h","status":"publish","type":"post","link":"https:\/\/www.hivnat.org\/en\/studies\/2002\/","title":{"rendered":"A phase 2\/3, open-label study of the pharmacokinetics, safety, and antiviral activity of the Elvitegravir\/Cobicistat\/Emtricitabine\/Tenofovir Alafenamide (E\/C\/F\/TAF) single tablet regimen (STR) in HIV-1 infected antiretroviral treatment-naive adolescents"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">This is an open-label, multicenter, two-part,\nsingle-arm study of the pharmacokinetics, safety, tolerability, and antiviral\nactivity of the single tablet regimen (STR)elvitegravir\/cobicistat\/emtricitabine\/tenofovir\nalafenamide (E\/C\/F\/TAF) in HIV 1 infected, ARV treatment naive adolescents\ndetermined by the achievement of HIV-1 RNA &lt; 50 copies\/mL Weeks 24 and 48 as\ndefined by the FDA snapshot analysis.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\t\t\t\tThis is an open-label, multicenter, two-part, single-arm study of the pharmacokinetics, safety, tolerability, and antiviral activity of the single tablet regimen (STR)elvitegravir\/cobicistat\/emtricitabine\/tenofovir alafenamide (E\/C\/F\/TAF) in HIV 1 infected, ARV treatment naive adolescents determined by the achievement of HIV-1 RNA < 50 copies\/mL Weeks 24 and 48 as defined by the FDA snapshot analysis.\t\t\n<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[24],"tags":[],"class_list":["post-2002","post","type-post","status-publish","format-standard","hentry","category-studies"],"_links":{"self":[{"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/posts\/2002","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/comments?post=2002"}],"version-history":[{"count":2,"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/posts\/2002\/revisions"}],"predecessor-version":[{"id":3326,"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/posts\/2002\/revisions\/3326"}],"wp:attachment":[{"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/media?parent=2002"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/categories?post=2002"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/tags?post=2002"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}